Every day Pharmacovigilance becomes increasingly important to patient health. There are some gaps and limitations in the current Latin American Pharmacovigilance framework which could be addressed to have a better system to correctly and promptly identify suspected adverse drug reactions (ADR). Considering this context, Vigilantia was born as an initiative to foster Pharmacovigilance both scientifically and educationally, and enhance all aspects of the safe and proper use of medicines, across all Latin America.
CarlosP., CarloC.-U., MarciaG.d.O., SaulL.P., JulianL.J., Marcelo MarioM.M. and ValderilioF.A., Recommendations on how to ensure the safety and effectiveness of biosimilars in Latin America: A point of view, Clin Rheumatol34 (2015), 635-640.
José JoaquiínM., MalhiC., DolorsM., JavierR. and JavierS., Elementos clave en la implantación de sistemas de notificación de eventos adversos hospitalarios en América Latina, Panam Salud Publica33(1) (2013), 1-7.
